| $0.00 (0 items)Checkout |
Categories list
Our billing is certified by:
product acomplia is not found!
Sorry we do not carry acomplia at this time.
- You can try to search acomplia in our product database - CLICK HERE TO SEARCH.
- Fill in the product request form and we will add the requested medicine shortly - PRODUCT REQUEST FORM
 |
|---|
 |
|---|
Good Morning:
The generic V is as expected, makes a good
thing better, and the price is such that it
is used all the time. Eliminates performance
anxiety !
Thank you for your help.
- Sincerely, Steve
 |
Bookmark this site |
|---|
 |
Subscribe to the News |
|---|
Latest News
- Gene 'may have shown Acomplia risk' - Pharmacy Europe
Gene 'may have shown Acomplia risk'Pharmacy EuropeAcomplia, produced by Sanofi-Aventis, had to be withdrawn because people taking part in a trial of the drug started killing themselves.
- Takeda Snags Orexigen's Obesity Drug in $1B-Plus Deal - BioWorld Online
Genetic Engineering NewsTakeda Snags Orexigen's Obesity Drug in $1B-Plus DealBioWorld OnlineAcomplia is not approved in the US and was withdrawn from the FDA registration process in 2007 after negative feedback from an FDA advisory panel.
- The Case Of Acomplia Highlights The Importance Of Genetic Testing - Pharmaceuticals & Healthcare Insight (registration)
The Case Of Acomplia Highlights The Importance Of Genetic TestingPharmaceuticals & Healthcare Insight (registration)Acomplia was once one of Sanofi-Aventis's potential blockbuster drugs, with annual sales forecast to be more than US$5bn by 2010 - especially as the .
- Arena's Lorcaserin: Weighed Down by Qnexa and Meridia - Seeking Alpha (blog)
Arena's Lorcaserin: Weighed Down by Qnexa and MeridiaSeeking Alpha (blog)In June 2007, the FDA rejected Sanofi-Aventis' (SNY) Acomplia saying that the drug's benefits did not outweigh its risks.
- The new diet pills: fad, fact or fiction? - MarketWatch
The new diet pills: fad, fact or fiction?MarketWatchA couple of years ago, Sanofi-Aventis finally abandoned its weight-loss drug Acomplia, also known as rimonabant, after European and US regulators voiced .